Panacea Capital (California) Overview

  • Investor Type
  • Venture Capital

  • Status
  • Active

  • Professionals
  • 12

Professionals

  • Investments
  • 53

  • Portfolio
  • 36

  • Exits
  • 8

Exits

Panacea Capital (California) General Information

Company Description

Founded in 2017, Panacea Capital is a venture capital firm based in San Francisco, California. The firm incubates early-stage technologies and medical sector companies. The firm seeks to invest across emerging and established biotech, diagnostic, and medtech sectors.

Business Details

Formerly Known As
Panacea Venture
Year Founded
2017
Investor Status
Actively Seeking New Investments
Primary Investor Type
Venture Capital
Other Investor Types
Accelerator/Incubator
Growth/Expansion
Corporate Office
  • Silicon Valley
  • San Francisco, CA
  • United States

Panacea Capital (California) Investments (53)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
Miragene 01-May-2026 Early Stage VC Drug Discovery Clinical Trials - Phase 1
Connect Biopharmaceuticals 30-Mar-2026 Drug Discovery Profitable
Seismic Pharmaceuticals 30-Mar-2026 Drug Delivery Clinical Trials - Phase 3
Lightning Biotherapeutics 01-Mar-2026 Biotechnology Stealth
Neurochase 17-Feb-2026 Drug Delivery Pre-Clinical Trials
Kainova Therapeutics 10-Feb-2026 Drug Discovery Clinical Trials - Phase 1
Biofront Therapeutics 01-Jun-2025 Drug Discovery Generating Revenue
VelaVigo 31-Dec-2024 Biotechnology Generating Revenue
Regatta Bio 17-Dec-2024 Seed Round Drug Discovery Pre-Clinical Trials
Human Longevity 21-Aug-2024 Later Stage VC Other Healthcare Services Generating Revenue
You’re viewing 10 of 53 investments. Get the full list »

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Panacea Capital (California) Exits (8)

Company Name Exit Date Exit Type Exit Size
HanchorBio 29-May-2026 IPO
Feng Biosciences 22-Aug-2025
ImageneBio 25-Jul-2025
Day Zero Diagnostics 13-Jun-2025
HC Bioscience 18-Mar-2025
Kindstar Global 16-Jul-2021
Orion Biotech Opportunities 13-May-2021 IPO
Zhaoke Ophthalmology 28-Apr-2021 IPO
To view Panacea Capital (California)’s complete exits history, request access »

Panacea Capital (California) Fund Performance

Fund Name Vintage Size Dry Powder DPI RVPI TVPI IRR

This information is available in the PitchBook Platform. To explore Panacea Capital (California)‘s full profile, request access.

Request a free trial

Panacea Capital (California) Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.

Request a free trial

Panacea Capital (California) FAQs

  • What is Panacea Capital (California)?

    Founded in 2017, Panacea Capital is a venture capital firm based in San Francisco, California.

  • When was Panacea Capital (California) founded?

    Panacea Capital (California) was founded in 2017.

  • Where is Panacea Capital (California) headquartered?

    Panacea Capital (California) is headquartered in San Francisco, CA.

  • How many investments has Panacea Capital (California) made?

    Panacea Capital (California) has made 53 investments.

  • What has Panacea Capital (California) invested in?

    Panacea Capital (California) has made numerous investments in companies like Miragene, Connect Biopharmaceuticals, and Seismic Pharmaceuticals within the Drug Discovery and Drug Delivery industries.

  • What has Panacea Capital (California) invested in recently?

    Panacea Capital (California)'s latest investment was on 01-May-2026 in Miragene, a company within the Drug Discovery industry.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process